US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 2.260
  • +0.010+0.44%
Close Apr 30 16:00 ET
  • 2.260
  • 0.0000.00%
Post 16:05 ET
168.01MMarket Cap-1.95P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
42.31%28.59M
193.60%12.93M
22.20%5.83M
-18.57%5.05M
1.43%4.78M
10.82%20.09M
1.58%4.4M
5.67%4.77M
33.67%6.2M
1.60%4.71M
Selling and administrative expenses
69.02%11.38M
309.48%5.74M
0.91%1.64M
10.74%1.97M
5.49%2.03M
8.28%6.73M
4.18%1.4M
5.47%1.62M
7.14%1.78M
15.32%1.93M
Research and development costs
26.38%17.21M
139.55%7.19M
29.90%4.19M
-32.19%3.08M
-3.60%2.75M
13.16%13.62M
-1.68%3M
8.18%3.23M
52.09%4.54M
-5.40%2.85M
Other operating expenses
----
----
----
----
----
-111.03%-260.5K
100.00%-1
-991.33%-79.57K
-1,676.71%-116.41K
-40.17%-64.52K
Operating profit
-42.31%-28.59M
-193.60%-12.93M
-22.20%-5.83M
18.57%-5.05M
-1.43%-4.78M
-10.82%-20.09M
-1.58%-4.4M
-5.67%-4.77M
-33.67%-6.2M
-1.60%-4.71M
Net non-operating interest income expense
0.78%1.07M
252.85%796.12K
-71.55%49.41K
-78.58%90.93K
-44.04%132.73K
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
424.44K
4,743,520.00%237.17K
Non-operating interest income
0.78%1.07M
252.85%796.12K
-71.55%49.41K
-78.58%90.93K
-44.04%132.73K
1,324.94%1.06M
303.47%225.63K
836.97%173.68K
--424.44K
--237.17K
Other net income (expense)
Income before tax
-44.62%-27.52M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
Income tax
Net income
-44.62%-27.52M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
Net income continuous Operations
-44.62%-27.52M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
Minority interest income
Net income attributable to the parent company
-44.62%-27.52M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-44.62%-27.52M
-190.40%-12.13M
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
Basic earnings per share
63.29%-1.16
74.28%-0.1749
13.33%-0.65
29.79%-0.66
25.51%-0.73
26.17%-3.16
33.33%-0.68
29.25%-0.75
14.55%-0.94
9.26%-0.98
Diluted earnings per share
63.29%-1.16
74.28%-0.1749
13.33%-0.65
29.79%-0.66
25.51%-0.73
26.17%-3.16
33.33%-0.68
29.25%-0.75
14.55%-0.94
9.26%-0.98
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 42.31%28.59M193.60%12.93M22.20%5.83M-18.57%5.05M1.43%4.78M10.82%20.09M1.58%4.4M5.67%4.77M33.67%6.2M1.60%4.71M
Selling and administrative expenses 69.02%11.38M309.48%5.74M0.91%1.64M10.74%1.97M5.49%2.03M8.28%6.73M4.18%1.4M5.47%1.62M7.14%1.78M15.32%1.93M
Research and development costs 26.38%17.21M139.55%7.19M29.90%4.19M-32.19%3.08M-3.60%2.75M13.16%13.62M-1.68%3M8.18%3.23M52.09%4.54M-5.40%2.85M
Other operating expenses ---------------------111.03%-260.5K100.00%-1-991.33%-79.57K-1,676.71%-116.41K-40.17%-64.52K
Operating profit -42.31%-28.59M-193.60%-12.93M-22.20%-5.83M18.57%-5.05M-1.43%-4.78M-10.82%-20.09M-1.58%-4.4M-5.67%-4.77M-33.67%-6.2M-1.60%-4.71M
Net non-operating interest income expense 0.78%1.07M252.85%796.12K-71.55%49.41K-78.58%90.93K-44.04%132.73K1,324.94%1.06M303.47%225.63K836.97%173.68K424.44K4,743,520.00%237.17K
Non-operating interest income 0.78%1.07M252.85%796.12K-71.55%49.41K-78.58%90.93K-44.04%132.73K1,324.94%1.06M303.47%225.63K836.97%173.68K--424.44K--237.17K
Other net income (expense)
Income before tax -44.62%-27.52M-190.40%-12.13M-25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M
Income tax
Net income -44.62%-27.52M-190.40%-12.13M-25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M
Net income continuous Operations -44.62%-27.52M-190.40%-12.13M-25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M
Minority interest income
Net income attributable to the parent company -44.62%-27.52M-190.40%-12.13M-25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -44.62%-27.52M-190.40%-12.13M-25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M
Basic earnings per share 63.29%-1.1674.28%-0.174913.33%-0.6529.79%-0.6625.51%-0.7326.17%-3.1633.33%-0.6829.25%-0.7514.55%-0.949.26%-0.98
Diluted earnings per share 63.29%-1.1674.28%-0.174913.33%-0.6529.79%-0.6625.51%-0.7326.17%-3.1633.33%-0.6829.25%-0.7514.55%-0.949.26%-0.98
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Meritage Homes
MTH
68.140
KB Home
KBH
54.030
D.R. Horton
DHI
126.340
4
Adobe
ADBE
374.980
5
Lennar Corp
LEN
108.610
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Earnings Season Underway

Earnings season is here. What to know?